Cell free fetal DNA to triage antenatal rhesus immune globulin: Is it really cost-effective in the United States?-Reference-Cited by-同舟云学术

Cell free fetal DNA to triage antenatal rhesus immune globulin: Is it really cost-effective in the United States?

Published:2019-01-24 Issue:3 Volume:39 Page:238-247
ISSN:0197-3851
Container-title:Prenatal Diagnosis
language:en
Short-container-title:Prenatal Diagnosis

Author:

Moise Kenneth J.¹^ORCID,Hashmi Syed Shahrukh²,Markham Kara³,Argoti Pedro S.⁴,Bebbington Michael⁴

Affiliation:

1. Department of Obstetrics, Gynecology and Reproductive Medicine, Division of Maternal-Fetal Medicine; McGovern School of Medicine, University of Texas Health Science Center at Houston; Houston TX USA

2. Department of Pediatrics, Pediatric Research Center; McGovern School of Medicine, University of Texas Health Science Center at Houston; Houston TX USA

3. Department of Obstetrics and Gynecology; Ohio State University College of Medicine; Columbus OH USA

4. Department of Obstetrics, Gynecology and Reproductive Medicine, Division of Maternal-Fetal Medicine; University of Texas School of Medicine at Houston; Houston TX USA

Publisher

Wiley

Subject

Genetics (clinical),Obstetrics and Gynecology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pd.5415/fullpdf

Reference30 articles.

1. Prenatal determination of fetal RhD status by analysis of peripheral blood of rhesus negative mothers;Lo;Lancet,1993

2. The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis;Mackie;BJOG,2017

3. Management and prevention of red cell alloimmunization in pregnancy: a systematic review;Moise;Obstet Gynecol,2012

4. Report of the first nationally implemented clinical routine screening for fetal RHD in D- pregnant women to ascertain the requirement for antenatal RhD prophylaxis;Clausen;Transfusion,2012

5. Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands;Haas;BMJ,2016

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of free DNA for fetal RHD genotyping in the Rh negative pregnant patient—the time has come;American Journal of Obstetrics and Gynecology;2024-08

2. Clinical Applications of Fetal Cell‐Free DNA: State of the Science;Journal of Midwifery & Women's Health;2024-07-25

3. Guideline No. 448: Prevention of Rh D Alloimmunization;Journal of Obstetrics and Gynaecology Canada;2024-04

4. Directive clinique no 448 : Prévention de l’allo-immunisation Rhésus D;Journal of Obstetrics and Gynaecology Canada;2024-04

5. Antenatal RHD screening to guide antenatal anti-D immunoprophylaxis in non-immunized D– pregnant women;Immunohematology;2024-04-01